Evidence map›Paper›PMID 42412846›Full record

ArticleBioinformatics (Oxford, England)2026

ProMeta: a meta-learning framework for robust disease diagnosis and prediction from plasma proteomics.

Han Li, Haoteng Gu, Lei Hu, Zimo Zhang, Yongji Lv, Peng Gao, Johnathan Cooper-Knock, Yaosen Min, Jianyang Zeng, Sai Zhang

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Han LiSchool of Mathematical Sciences and LPMC, Nankai University, Tianjin, 300071, China.
Haoteng GuSchool of Computer Science, Beijing University of Technology, Beijing, 100124, China.
Lei HuDepartment of Artificial Intelligence, School of Engineering, Westlake University, Hangzhou, 310030, China.
Zimo ZhangDepartment of Artificial Intelligence, School of Engineering, Westlake University, Hangzhou, 310030, China.
Yongji LvDepartment of Artificial Intelligence, School of Engineering, Westlake University, Hangzhou, 310030, China.
Peng GaoDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, United States.
Johnathan Cooper-KnockSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, S10 2HQ, United Kingdom.
Yaosen MinZhongguancun Institute of Artificial Intelligence, Beijing, 100085, China.
Jianyang ZengDepartment of Artificial Intelligence, School of Engineering, Westlake University, Hangzhou, 310030, China.
Sai ZhangDepartment of Biomedical Informatics & Data Science, Yale School of Medicine, New Haven, CT, 06510, United States.

Funding

Fundamental and Interdisciplinary Disciplines Breakthrough Plan of the Ministry of Education of China JYB2025XDXM502National Key R&D Program of China 2024YFC3407800National Key R&D Program of China 2025YFC3410200National Natural Science Foundation of China 32430062National Natural Science Foundation of China 92478001National Natural Science Foundation of China T2125007Natural Science Foundation of Tianjin 25JCQNJC01180New Cornerstone Science Foundation XPLORR PRIZENoncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0525100Pioneer" and "Leading GooseR&D Program of Zhejiang 2026C01039Research Center for Industries of the FutureState Key Laboratory of Gene ExpressionWestlake Center for Genome Editing 21200000A992410/004Westlake Education FoundationWestlake UniversityZhejiang Leading Innovative and Entrepreneur Team Introduction Program 2024R01007
6 · The paper itself

Abstract

motivationThe plasma proteome offers a dynamic window of human health, capturing the real-time intersections between genetics and physiology. However, the application of deep learning to proteomics is currently hindered by a reliance on large-scale labeled datasets, rendering standard models ineffective for rare or novel diseases where patient samples are inherently scarce.

resultsHere, we present ProMeta, a meta-learning framework designed to enable robust disease modeling under extreme data restrictions. By integrating knowledge-guided pathway encoding with bi-level meta-optimization, ProMeta projects unstructured proteomic profiles into biologically interpretable functional tokens. This architecture allows the model to learn a global initialization containing transferable biological priors from biobank-scale data, facilitating rapid adaptation to novel tasks. Through comprehensive benchmark experiments, ProMeta consistently outperformed transfer learning and traditional machine learning baselines in both disease diagnosis and prediction tasks. In the most challenging 4-shot scenarios (utilizing only 2 cases and 2 controls), the model achieved robust generalization with an average AUROC of ∼0.69, representing a 24.6% relative improvement over the best-performing baseline methods. Mechanistic investigation revealed that ProMeta disentangles cases from controls in the latent space prior to task-specific adaptation, confirming the acquisition of universal biological rules rather than rote memorization. Furthermore, gradient-based interpretation identified disease-specific protein biomarkers and functional pathways consistent with known pathophysiology. Collectively, ProMeta overcomes the data-scarcity bottleneck in precision medicine, providing a scalable, interpretable framework for characterizing the full spectrum of human diseases, particularly for rare conditions lacking extensive clinical cohorts. AVAILABILITY AND IMPLEMENTATION: The source code of ProMeta is available at GitHub (https://github.com/lihan97/ProMeta).

Indexed as

Blood ProteinsComputational BiologyMachine LearningProteomeProteomicsHumansPredictive Learning ModelsBlood ProteinsProteome

Identifiers

PMID42412846
PMCPMC13340251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.